Experts discuss the importance of continuous, real-time monitoring in preclinical research, sharing case studies including using continuous EEG monitoring for sleep studies and using telemetry in Biodefense research.

During this exclusive webinar sponsored by Data Sciences International, Steve Fox, Associate Principal Scientist at Merck Research Labs, shares his experience from pharmaceutical development, discussing the importance of continuous EEG monitoring as a biomarker for CNS activity and drug discovery. Anna Honko, Staff Scientist at NIH/NIAID, explains the importance of having access to real-time, continuous data when studying infectious diseases in non-human primates in a Biodefense setting. In addition, Dusty Sarazan, CSO at Data Sciences International, reminds viewers how and why continuous, real-time monitoring has become not only the preferred, but essential method, for acquiring and studying physiology in today’s preclinical research setting.

Click to watch the webinar recording. To view the presentation full screen simply click the square icon located in the bottom-right corner of the video-viewer.

Resources

To download a PDF copy of the presentation, click on the “LinkedIn SlideShare” icon located in the bottom-right corner of the slide-viewer. From the SlideShare landing page click the “Download” button to retrieve the file.

Presenters

Associate Professor
School of Medicine
Boston University

Anna Honko, PhD recently joined Boston University’s National Emerging Infectious Diseases Laboratories (NEIDL) as a Research Associate Professor. In the Nonclinical Studies Unit, she’ll be directing well-documented, Animal Rule and GLP studies to advance anti-viral medical countermeasure development. Dr. Honko's background is in immunology and vaccine development, with a later emphasis in biothreat and emerging infectious diseases. She has a focus on regulated studies as well a passion for radiotelemetry monitoring.

Associate Principal Scientist
Merck & Co., Inc

Vice President & Chief Scientific Officer
Data Sciences International

Production Partner

Data Sciences International

Data Sciences International (DSI) is the leader in preclinical physiological monitoring offering telemetry, instrumentation, software and services to help advance science. Industries served include: Pharmaceuticals, Academia, Contract Research Organizations, Biological and Chemical Defense, Medical Devices, Government, and Biotechnology.

Harvard Bioscience, Inc.

Harvard Bioscience is a global leader in the manufacturing and distribution of solutions to advance life science research. For over 110 years, we have served the changing needs of life scientists in over 100 countries. Our expanding portfolio of brands include instruments for organ and animal research, cell analysis, molecular biology, fluidics, and laboratory consumables.

Additional Content From Data Sciences International

Additional Content From Harvard Bioscience, Inc.

Related Content

Fishing for Insights from Single-Lead and Multi-Lead ECG of Live Adult Zebrafish

Fishing for Insights from Single-Lead and Multi-Lead ECG of Live Adult Zebrafish

In this webinar, Dr. Thao Nguyen discusses the exciting discoveries that her research team has made, debunks some common myths, and shares best-practices for data acquisition, analysis, and interpretation. Her in vivo studies of adult zebrafish cardiac electrophysiology rely on single-lead and multi-lead surface ECG in live anesthetized adult zebrafish.
Myeloid Cells and Cardiovascular Health

Myeloid Cells and Cardiovascular Health

Dr. Matthias Nahrendorf discusses current concepts of cell supply by the hematopoietic system, highlights open questions, and describes imaging tools for studying monocytes, macrophages and their progenitors.